The menstrual cycle phase impacts the detection of plasma cells and the diagnosis of chronic endometritis in endometrial biopsy specimens

• Published in: Fertility and sterility Vol. 118; no. 4; pp. 787 - 794
• Main Authors: Ryan, Emily, Tolani, Alisha T, Zhang, Jiaqi, Cruz, Giovanna I, Folkins, Ann K, Lathi, Ruth B
• Format: Journal Article
• Language: English
• Published: United States 01.10.2022
• Subjects: Biopsy; Chronic Disease; Endometritis - diagnosis; Endometritis - pathology; Endometrium - pathology; Eosine Yellowish-(YS); Female; Hematoxylin; Hormones; Humans; Luteal Phase; Menstrual Cycle; Plasma Cells - pathology; Retrospective Studies; Chronic endometritis; cycle timing; infertility; endometrial biopsy
• ISSN: 0015-0282; 1556-5653
• DOI: 10.1016/j.fertnstert.2022.07.011

To assess the impact of menstrual cycle phase on the detection of plasma cells. A retrospective cohort study. Fertility clinic. Biopsies from 157 patients met criteria for inclusion, 91 in the follicular phase and 60 in the luteal phase. Patient groups were similar in body mass index and number of previous live births; however, differed in terms of age, infertility history, and biopsy indication. Endometrial biopsies from patients at a fertility clinic from 2018-2020 were retrospectively reviewed. Biopsies were excluded if patients had a previous chronic endometritis diagnosis, abnormal uterine cavity or were on hormone therapy. Each case was reviewed by a gynecologic pathologist for plasma cells by hematoxylin and eosin and CD138 staining. Demographic and clinical data were collected. Continuous variables were compared using Welch t test and Wilcoxon's rank sum test, and categorical variables using Pearson's χ test. Logistic regression was used to calculate odds ratio and 95% confidence intervals for the association between the presence of plasma cells and cycle phase. Multinomial logistic regression was used to estimate the odds ratios for nominal outcomes. Pathology reports were reviewed. Plasma cell enumeration using hematoxylin and eosin-stained sections and CD138 immunohistochemical stains (performed at the time of biopsy by a gynecologic pathologist) was recorded. Presence and density of plasma cells. We found a higher likelihood of finding plasma cells in the follicular than in luteal phase (59.3% vs. 19.7%). There was a higher likelihood of finding plasma cells in the early (cycle days 5-8, 29 cases or 76.3% of cases with plasma cells) than in the late follicular phase (cycle days 9-14, 25 cases or 47.2%). There was a higher density of plasma cells in the follicular phase group than in the luteal phase group (25.3% vs. 1.5% scattered and 13.2% vs. 0 clusters). Plasma cells are more likely to be present during the follicular phase compared with the luteal phase and in the early compared with the late follicular phase. Further studies are needed to identify the optimal timing of biopsy to standardize the diagnosis.